← Evidence map

ReviewEndocrine2021

Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer.

Helton Estrela Ramos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32691271